Lataa...
Survival and desferrioxamine in thalassaemia major.
A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future t...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1982
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1497956/ https://ncbi.nlm.nih.gov/pubmed/6802413 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|